Kenta Aso

Dr. Kenta Aso

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2026 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
KAKenta Aso
Kenta Aso
TTTakeda Takeda
Takeda Takeda
ATAtsushi Takahashi
Atsushi Takahashi
SIShoichi Irie
Shoichi Irie
YHYoshihiro Hirata
Yoshihiro Hirata
ASAkio Saiura
Akio Saiura


1 January 2026 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
SASaho Aso
Saho Aso
MTMoe Tasaki
Moe Tasaki
KAKenta Aso
Kenta Aso
YIYuzuru Ito
Yuzuru Ito
SSShunsuke Shirakawa
Shunsuke Shirakawa
HSHiroyuki Sugo
Hiroyuki Sugo
INTRODUCTION: A malignant sigmoid colon–duodenal fistula is extremely rare, and optimal management strategies remain unclear.CASE PRESENTATION: A 66-year-old man was admitted to a local hospital with melena. Lower gastrointestinal endoscopy identified a circumferential type 3 tumor located in the sigmoid colon. Upper gastrointestinal endoscopy revealed extrinsic tumor invasion into the horizontal portion of the duodenum. Contrast-enhanced abdominal CT demonstrated irregular thickening of the sigmoid colon wall, which appeared to be contiguous with the horizontal portion of the duodenum, with evidence of luminal continuity. Based on a diagnosis of malignant sigmoid–duodenal fistula, the patient underwent open surgery. At laparotomy, the sigmoid colon cancer was found to be directly invading the duodenojejunal flexure, arising from the ligament of Treitz on the left side of the superior mesenteric artery, which made preservation of the duodenum difficult. Therefore, Hartmann’s procedure with concomitant segmental duodenectomy was performed while preserving the pancreas. For duodenal reconstruction, a Roux-en-Y jejunal limb was created and anastomosed to the second portion of the duodenum. Additionally, a gastrojejunostomy in the Billroth II configuration was performed.CONCLUSIONS: Malignant invasion of the duodenum is often associated with involvement of major vessels or the need for pancreatic resection, which may render curative resection difficult or excessively invasive. However, segmental duodenectomy with preservation of the pancreas can be a valuable surgical option in selected cases.

24 August 2026 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
PDF file
KAKenta Aso
Kenta Aso
TTTakeda Takeda
Takeda Takeda
ASAkio Saiura
Akio Saiura

8 March 2026 in Cancers
Verified
Journal Article
Open access
PDF file
KAKenta Aso
Kenta Aso
RYRyuji Yoshioka
Ryuji Yoshioka
ATAtsushi Takahashi
Atsushi Takahashi
SIShoichi Irie
Shoichi Irie
TTTakeda Takeda
Takeda Takeda
ASAkio Saiura
Akio Saiura
Background/Objectives: Differentiating pancreatic head cancer (PHC) from distal cholangiocarcinoma (dCCA) remains clinically challenging and directly influences treatment strategy. This study evaluates the clinicopathologic features and outcomes of patients with PHC who were preoperatively designated as dCCA. Methods: We retrospectively analyzed patients undergoing pancreatoduodenectomy for suspected dCCA or PHC from 2019 to 2023. Patients were stratified by pre- and postoperative diagnoses into three groups: confirmed dCCA (B-B), confirmed PHC (P-P), and dCCA reclassified as PHC (B-P). Clinicopathologic features, perioperative outcomes, and survival were compared. Results: This analysis included 159 patients, B-B = 31, P-P = 115, and B-P = 13. Despite a more advanced stage, a lower R0 rate (p = 0.043), and unplanned portal vein resection confined to B-P (p < 0.001), overall and recurrence-free survival were comparable to P-P (p = 0.363 and 0.183). In multivariable Cox analysis, B-P remained an independent favorable prognostic factor for overall survival (Hazard ratio 0.137, p = 0.020). Conclusions: Approximately one-third of cases initially diagnosed as dCCA were ultimately PHC. These PHC cases mimicking dCCA demonstrated comparable or even superior survival, suggesting a biologically indolent subset. Refinement of diagnostic criteria and integrated clinicopathologic assessment are essential for optimizing preoperative management strategies.